Searched for
MS GANESH
Kara OTT release details: When and where to watch Dhanush's Tamil action thriller movie online after its theatrical runDhanush’s action thriller Kara, directed by Vignesh Raja, was released in theatres on April 30, 2026. Set in Tamil Nadu during the 1991 Gul...- Buy Zydus Lifesciences, target price Rs 530: Yes SecuritiesBullish ABC breakout suggests follow through moves on P&F chart.
- Buy Zydus Lifesciences, target price Rs 572: Sharekhan by BNP ParibasZydus Lifesciences, incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 46161.57 Crore) operating in Pharmaceu...
- Buy Zydus Lifesciences, target price Rs 488: HDFC SecuritiesStock price is in an attempt of decisive upside break-out of resistance of top of Nov at Rs 454 levels.
- Buy Zydus Lifesciences, target price Rs 470: JM FinancialZydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Phar...
- Buy Zydus Lifesciences., target price Rs 426: Angel OnePromoters held 74.98 per cent stake in the company as of 30-Sep-2022, while FIIs owned 2.86 per cent, DIIs 12.85 per cent.
- CLSA retains buy on Cadila Healthcare, raises target price to Rs 330The brokerage has raised earnings estimates by 2-10% to reflect the strong earnings beat in the third quarter.
- Buy Cadila Healthcare, price target Rs 295: Kunal BothraThe analyst suggested a stoploss at Rs 250.
- Buy Cadila Healthcare, price target Rs 278: Sagar DoshiThe analyst suggested a stoploss at Rs 245.
- Buy Cadila Healthcare. target Rs 250: Abhijit PathakBuy Cadila Healthcare Ltd. at a price target of Rs 250.0 and a stoploss at Rs 230 from entry point.
- Buy Cadila Healthcare, target Rs 248: Sagar DoshiBuy Cadila Healthcare Ltd. at a price target of Rs 248.0 and a stoploss at Rs 216 from entry point.
- Sell Cadila Healthcare, target Rs 373: Dharmesh ShahSell Cadila Healthcare Ltd. at a price target of Rs 373.0 and a stop loss at Rs 402 from entry point.
- Buy Cadila Healthcare, target Rs 435: Manas JaiswalBuy Cadila Healthcare Ltd. at a price target of Rs 435.0 and a stop loss at Rs 419 from entry point.
- Sell Cadila Healthcare, target Rs 445: Manas JaiswalSell Cadila Healthcare at a price target of Rs 445 and a stop loss at Rs 470 from entry point.
- Supreme Court refuses to hear Sahara plea on Mirach immediatelySahara has also moved the top court with a plea to extend special video-conferencing facilities again at Tihar jail to Roy to enable him to...
- Supreme Court doubts Sahara's ability to raise 10,000 Crore for Subrata Roy bailRoy has previously been allowed the use of conference facilities at Tihar jail as he sought to sell three overseas hotel properties to help...
- SC may ask external agency to handle Sahara property saleThe top court suggested Naphade suggest names of entities that can sell such large properties to raise funds to free Roy, who has been in T...
- Sahara chief seeks 15 more days from Supreme Court to sell propertiesThe court said that it will take up his plea if it is possible for the special bench, hearing his case, to assemble on that day.
- ALD Vacuum Technologies picks up 30 per cent in Dynatech FurnacesLeading global supplier of vacuum furnaces, ALD Vacuum Technologies GmbH, Germany, has picked up 30 per cent stake in Dynatech Furnaces (Bo...
- Contemporary, modern Bengal art to feature at Sept auctionThis is the first time that an auction is being dedicated exclusively to Bengal art. As things stand, the gallery has decided to combine bo...
Load More
